implantable

MIV Therapeutics Announces Renowned Researcher to Detail Milestone Pre-Clinical Results at Prominent International Conference EuroPCR 2007

...elivery systems forCardiovascular stents and other implantable medical devices, ispleased to announce that result...y as a bone substitutematerial and for coatings on implantable fixation devices inorthopedic, dental and other applications. The Company's novelpolymer-free drug e...

Intarcia Therapeutics Announces Presentation of Final Results From a Phase 2 Combination Study for the Treatment of Hepatitis C at the Digestive Disease Week Conference

...t dose of omega interferon for three monthsvia the implantable DUROS device, a drug delivery technologydeveloped by ALZA Corporation, and licensed to Intarcia for use incertain broad fields. Another product incorporating the DUROStechnology has already been approved by the FDA for the palliativetreatment of pros...

Positive Statistical Analysis from Synthetic Blood's Oxycyte Traumatic Brain Injury Trial Indicates Achievement of Primary Endpoint

...ood substitute, a liquidventilation product and an implantable glucose sensor. Theseproducts are based upon core technologies that include biomedicalapplications for perfluorocarbons, and medical and industrialapplications for biosensors. Each of the product candidates isdesigned with advantages over currently m...

Intarcia Therapeutics Announces Final Results From a Phase 2 Study of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1

...s through the delivery of omegainterferon with the implantable DUROS device." The Phase 2 trial compared the saf...t dose of omega interferon for three monthsvia the implantable DUROS device, a drug delivery technologydeveloped by ALZA Corporation, and licensed to Intarcia for ...

MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines

...elivery systems forcardiovascular stents and other implantable medical devices, todayannounced that a recent Comp...y as a bone substitutematerial and for coatings on implantable fixation devices inorthopedic, dental and other applications. The Company's novelpolymer-free drug e...